Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
03/27/2003 | US20030059869 Novel G protein-coupled receptor, GAVE3 |
03/27/2003 | US20030059866 Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon |
03/27/2003 | US20030059860 Antibody for use in the classification and detection of parasitic infection of mammals |
03/27/2003 | US20030059859 Vertebrate protein for use in human therapeutic and diagnostics |
03/27/2003 | US20030059835 Nucleotide sequence coding red fluorescent protein for use as diagnostic tool in genetic analysis |
03/27/2003 | US20030059812 HDAC9 polypeptides and polynucleotides and uses thereof |
03/27/2003 | US20030059805 Nucleotide sequences coding polyeptide for use in the treatment of growth disorders in humans |
03/27/2003 | US20030059802 Nucleotide sequences coding polypeptide for use in the prevention and treatment of infection of gut and intestine; for use aide in digestion and nutrient absorption |
03/27/2003 | US20030059799 Modified DNA molecule, recombinant containing the same, and uses thereof |
03/27/2003 | US20030059793 Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof |
03/27/2003 | US20030059779 Promotor for functional characterization of G-protein coupled receptors in the yeast saccharomyces cerevisiae |
03/27/2003 | US20030059461 Molecular delivery vehicle for delivery of selected compounds to targets |
03/27/2003 | US20030059442 Attenuated microorganisms for the treatment of infection |
03/27/2003 | US20030059441 Unmarked mutation is a mutated nucleotide sequence introduced into mycobacterium where sequence does not contain selectable marker such as gene conferring antibiotic resistance to recombinant mycobacterium incorporating mutated sequence |
03/27/2003 | US20030059437 Invention is based on identification of proteins (including agonist and antagonist antibodies) which either stimulate or inhibit immune response in mammals; immune related diseases can be treated by suppressing or enhancing immune response |
03/27/2003 | US20030059431 Prostatic growth factor |
03/27/2003 | US20030059421 DNA encoding the baboon and cynomolgus macaque prostoglandin E2 receptor EP4 subtype |
03/27/2003 | US20030059417 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
03/27/2003 | US20030059400 Comprises DNA sequence encoding a detectable, cytotoxic protein or protein capable of inducing a detectable signal (luminescent or fluorescent); tumor imaging; gene expression |
03/27/2003 | CA2461065A1 Transductin-1 and transductin-2 and applications to hereditary deafness |
03/27/2003 | CA2460819A1 Methods and apparatuses for purification |
03/27/2003 | CA2460812A1 Lipid-associated molecules |
03/27/2003 | CA2460808A1 Immune response associated proteins |
03/27/2003 | CA2460546A1 Dna polymerases and mutants thereof |
03/27/2003 | CA2460505A1 Nucleic acid for a cloning vector |
03/27/2003 | CA2460499A1 A gene encoding cyclododecanone monooxygenase |
03/27/2003 | CA2460460A1 Fermentation product of cryptoporus volvatus and its preparation method and use |
03/27/2003 | CA2460372A1 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses |
03/27/2003 | CA2460048A1 Novel peptide, novel adsorbent, adsorption unit and adsorption method |
03/27/2003 | CA2459761A1 Device and method for concentration and detection of pathogenic germs from blood products and/or their derivatives |
03/27/2003 | CA2459219A1 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer |
03/27/2003 | CA2459140A1 Protein modification and maintenance molecules |
03/27/2003 | CA2459022A1 Neurotransmission-associated proteins |
03/27/2003 | CA2445205A1 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor |
03/26/2003 | WO2002026978A1 Novel proteins, genes encoding them and method of using the same |
03/26/2003 | EP1295945A1 Human neuronal nictinic acetylcholine receptor compositions and mehtods employing same |
03/26/2003 | EP1295939A1 Insulin-like growth factor binding protein |
03/26/2003 | EP1295937A2 Candida boidinii formic hydrogenase mutants |
03/26/2003 | EP1295897A1 DNA encoding the chimpanzee prostaglandin E2 receptor EP4 subtype |
03/26/2003 | EP1295895A1 Peptides and Protins binding to glu-pro motifs, therapeutical compositions containing them and their applications |
03/26/2003 | EP1294952A1 Hiv-1 reporter viruses and their use in assaying anti-viral compounds |
03/26/2003 | EP1294916A2 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants |
03/26/2003 | EP1294910A2 Protein glycosylation modification in pichia pastoris |
03/26/2003 | EP1294909A2 Natural promoters for gene expression and metabolic monitoring in bacillus species |
03/26/2003 | EP1294905A1 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest |
03/26/2003 | EP1294895A2 Calpain protease 12 |
03/26/2003 | EP1294894A2 Human protein kinase "13305" and uses therefor |
03/26/2003 | EP1294893A2 Modification of hepatitis b core antigen |
03/26/2003 | EP1294892A2 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
03/26/2003 | EP1294888A2 Interferon-like protein zcyto21 |
03/26/2003 | EP1294887A1 Insulin homolog polypeptide zins4 |
03/26/2003 | EP1294886A2 THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IGE ANTIBODY AND USES THEREOF |
03/26/2003 | EP1294885A2 B7-like molecules and uses thereof |
03/26/2003 | EP1294884A2 Secretion and trafficking molecules |
03/26/2003 | EP1294883A2 Human extracellular matrix (ecm)-related tumor marker |
03/26/2003 | EP1294882A2 B7-like molecules and uses thereof |
03/26/2003 | EP1294880A2 Antimicrobial peptides of the family of defensins, polynucleotides encoding said peptides, transformed vectors and organisms containing them |
03/26/2003 | EP1294879A2 Thymic stromal lymphopoietin receptor molecules and uses thereof |
03/26/2003 | EP1294873A1 Tumour suppressor and uses thereof |
03/26/2003 | EP1294871A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof |
03/26/2003 | EP1294870A1 Nucleic acid sequences and methods for the modification of plant gene expression |
03/26/2003 | EP1294868A2 Adenylyl and guanylyl cyclases |
03/26/2003 | EP1294867A1 Human site-1 protease promoter |
03/26/2003 | EP1294864A2 Mutated furin polypeptides having improved characteristics |
03/26/2003 | EP1294863A2 Detection of rna |
03/26/2003 | EP1294859A1 Novel laccase enzyme and the gene encoding the enzyme |
03/26/2003 | EP1294856A1 DNAs ENCODING MAMMALIAN HISTAMINE RECEPTOR OF THE H4 SUBTYPE |
03/26/2003 | EP1294853A2 Universal collection medium |
03/26/2003 | EP1294852A1 Enhanced flavour production in or relating to food by cultivation of various food-grade micro-organisms |
03/26/2003 | EP1294850A1 A microbial pesticide active against plant fungal pathogens and process for preparation thereof |
03/26/2003 | EP1294849A1 Micro-organisms active in the digestive environment |
03/26/2003 | EP1294770A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
03/26/2003 | EP1294769A1 Antibodies that immunospecifically bind to blys |
03/26/2003 | EP1294765A2 Il-17 molecules and uses thereof |
03/26/2003 | EP1294763A2 Secreted proteins |
03/26/2003 | EP1294755A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
03/26/2003 | EP1294754A1 Interferon-alpha induced gene |
03/26/2003 | EP1294753A2 A human homologue of the db4/ask1 protein, nucleic acids, and methods related to the same |
03/26/2003 | EP1294751A1 Dermacentor variabilis gaba-gated chloride channels |
03/26/2003 | EP1294749A2 Use of recombinant antigens to determine the immune status of an animal |
03/26/2003 | EP1294748A2 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same |
03/26/2003 | EP1294746A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
03/26/2003 | EP1294745A2 Antimicrobial peptides and methods of use thereof |
03/26/2003 | EP1294738A2 Novel motor proteins and methods for their use |
03/26/2003 | EP1035776B1 Fungi of the genus piriformospora |
03/26/2003 | EP1025052B1 Method for reducing the effect of detergents upon germination and/or growth of microorganisms |
03/26/2003 | EP0939809B1 Tie-2 receptor ligand (tie ligand-4) and its use |
03/26/2003 | EP0870016B1 Enzymes, their preparation and their use in the production of ammonium acrylate |
03/26/2003 | EP0843734B1 Integrated nucleic acid diagnostic device |
03/26/2003 | EP0835261B1 Ion channel |
03/26/2003 | EP0833658B1 Inhibin compositions and methods of enhancing production performance |
03/26/2003 | EP0802975B1 Process for reducing rna concentration in a mixture of biological material using diatomaceous earth |
03/26/2003 | CN2541464Y Stair photosynthetic germ culture appts. |
03/26/2003 | CN2541463Y Culture appts. for single cell Algae |
03/26/2003 | CN1406278A Expression of recombinant mature lysostaphin |
03/26/2003 | CN1406275A Microorganism producing L-lysine and processes for producing L-lysine usi ng the same |
03/26/2003 | CN1406274A Novel lactobacillus paracasei subsp. paracasei strain antibacterial against nelicobacter pylori and escherichia coli 157:H7 |
03/26/2003 | CN1406273A Microorganism producing 5'-inosinic acid and process for producing 5'-inosinic acid using the same |
03/26/2003 | CN1405314A Cryptoporus volvatus fermented product, and its preparation method and application |
03/26/2003 | CN1405306A Specific bacteria preparation and method for treating chemical waste water or conventional organic waste water |